ANDA 210917, held by Ingenus Pharms LLC. Leucovorin Calcium.
As of Nov 16, 2026, ANDA 210917 (Leucovorin Calcium), held by Ingenus Pharms LLC, was first approved by FDA on Nov 23, 2018, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Nov 23, 2018 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Leucovorin CalciumEQ 500MG BASE/50ML (EQ 10MG BASE/ML) ยท solution;intramuscular, intravenous | Leucovorin Calcium | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters